The store will not work correctly when cookies are disabled.
N-Hydroxy-4-(quinolin-4-ylamino)benzamide
ID: ALA4752558
PubChem CID: 162652776
Max Phase: Preclinical
Molecular Formula: C16H13N3O2
Molecular Weight: 279.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NO)c1ccc(Nc2ccnc3ccccc23)cc1
Standard InChI: InChI=1S/C16H13N3O2/c20-16(19-21)11-5-7-12(8-6-11)18-15-9-10-17-14-4-2-1-3-13(14)15/h1-10,21H,(H,17,18)(H,19,20)
Standard InChI Key: CRQRFXAGXWHWTJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
16.5172 -24.1525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5172 -24.9697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2224 -25.3742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2224 -23.7398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9277 -24.1525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9288 -24.9697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6331 -25.3752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6310 -23.7408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6288 -22.9236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3354 -22.5131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0453 -22.9219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7498 -22.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7518 -21.6974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0432 -21.2885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3325 -21.6971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4600 -21.2896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1673 -21.6989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4609 -20.4724 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1691 -20.0646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3357 -24.1482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3447 -24.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 4 1 0
2 3 1 0
3 6 2 0
5 4 2 0
5 6 1 0
5 8 1 0
6 7 1 0
7 21 2 0
20 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
10 15 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
13 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
20 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.30 | Molecular Weight (Monoisotopic): 279.1008 | AlogP: 3.10 | #Rotatable Bonds: 3 |
Polar Surface Area: 74.25 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.24 | CX Basic pKa: 7.29 | CX LogP: 2.32 | CX LogD: 2.17 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.51 | Np Likeness Score: -1.04 |
References
1. Tseng HJ,Lin MH,Shiao YJ,Yang YC,Chu JC,Chen CY,Chen YY,Lin TE,Su CJ,Pan SL,Chen LC,Wang CY,Hsu KC,Huang WJ. (2020) Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease., 192 [PMID:32151835] [10.1016/j.ejmech.2020.112193] |